# 1 what kind of Cardio-vascular diseases of the people #
:::warning
Kung nagsimula na ang pag-inom ng gamot para sa mataas na presyon, hindi ibig sabihin na hindi na maaaring gawin ang karagdagang mga hakbang para palakasin ang katawan sa programa ng therapy. Ang benepisyo ng maingat na mga hakbang na pinagkasunduan ng doktor ay nakakatulong para mapigilan ang paglala ng sakit at maiwasang lumipat ito sa mas seryosong yugto.
:::
[](https://cardio-balance-ph.store-best.net)
<div style="height:500px;"></div>
## The reasons for the development of cardiovascular diseases ##
<div class="alert alert-info" role="alert">
Ang mga modernong gamot sa pag-imprenta ay hinahati sa 10 iba't ibang grupo ayon sa kanilang mekanismo ng pagkilos. Pagkatapos suriin ng doktor ang mga reklamo ng pasyente at ang resulta ng mga pagsusuri, nagrereseta siya ng isa o higit pang gamot, na hindi dapat baguhin nang mag-isa. Ang mga gamot sa puso at daluyan ng dugo ay hindi kabilang sa mga puwedeng irekomenda sa kaibigan. Ang maling desisyon ay maaaring magdulot ng malungkot na kahihinatnan. Lahat ng gamot na pampababa ng presyon ng dugo ay kailangan ng reseta. Sa artikulong ito, tinitingnan natin ang kanilang modernong klasipikasyon base sa mga aktibong sangkap at sa paraan ng epekto nito sa katawan.
</div>
Cardiovascular disease: Definition and an important Form of coronary heart disease
Cardiovascular or circulatory-related diseases (in German often as cardiovascular diseases referred to) are a group of diseases that affect the heart and blood vessel system. These diseases are among the leading causes of death in the world and include a variety of different diseases.
One of the most common and important forms of cardiovascular diseases coronary heart disease (Coronary heart disease, English, Coronary Artery Disease, CAD) is.
Definition and pathophysiology
Coronary heart disease is characterized by a narrowing or occlusion of the coronary arteries, the blood vessels that supply the heart muscle tissue (myocardium) with oxygen-rich blood. The underlying cause of these changes of atherosclerosis, the formation of Plaques (deposits) is usually in the inner vessel wall.
These Plaques are made up of lipids (especially cholesterol), inflammatory cells, smooth muscle cells and fibrous tissue. Over time, they lead to calcification and stiffening of the arterial wall, as well as a restrictive narrowing of the vessel lumen (stenosis).
Follow and clinical manifestations
Due to the reduced blood flow to the heart muscle can lead to a lack of oxygen (ischemia), which can cause the following clinical pictures:
Angina pectoris: episodic chest pain or tightness due to myocardial ischemia during physical exertion or Stress.
Myocardial infarction: an acute occlusion of a coronary artery leads to the death of a part of the heart muscle.
Congestive heart failure: long-term damage to the heart can interfere with its function.
Arrhythmias: disturbances of the heart rhythm as a result of damage to the electrical conduction system of the heart.
Risk factors
One of the most important modifiable risk factors for the development of coronary heart disease include:
Hypertension (High Blood Pressure)
Hyperlipidemia (elevated blood fats, in particular, LDL‑cholesterol)
Tobacco use
Diabetes mellitus
Overweight and obesity
Lack of exercise
Eating habits
Non-modifiable factors are age, gender (men are affected up to the menopause age) and a family history of early cardiovascular events.
Conclusion
Coronary heart disease as a Central Form of cardiovascular disease demonstrates the importance of prevention and early Intervention. Through the influence of risk factors and early diagnosis of the disease risk can be significantly lower, and the quality of life and expectations of the individuals.
> People have long used Hawthorne berries for treating high bp, heart issues, and cholesterol levels. A number of Clinical research conclude that it improves cardiovascular function, shortness of breath, and fatigue. In another study, 1200 mg hawthorn extract or placebo was taken by hypertension patients for 16 weeks. Those who were taking hawthorn extract had a significant decrease in blood pressure than the other group taking a placebo.
<a href="http://www.leader.puszczaknyszynska.org/userfiles/heart-disease-due-to-high-blood-pressure.xml">http://www.leader.puszczaknyszynska.org/userfiles/heart-disease-due-to-high-blood-pressure.xml</a>
Nililinis ang mga ugat na kailangang alagaan mula sa deposito at pinananatili ang kinakailangang lakas ng tibok ng puso! <a href="http://www.diskacme.dk/images/upload/cardiovascular-disease-krasnodar-region.xml">Presyong pang-promosyon</a>
## Modern medicines for high blood pressure-acting ##
Of course! Here is a scientific Text on the subject is a Modern medication for high blood pressure:
Modern drugs for the treatment of high blood pressure (hypertension)
High blood pressure, or medical hypertension, is one of the most common chronic diseases in the world and is regarded as a major risk factor for cardiovascular diseases such as heart attack, stroke, and kidney damage. The WHO estimates that approximately 1.28 billion adults aged 30 to 79 years suffer from hypertension, with a large number of Affected and treated the disease adequately.
Goals of therapy
The main goal of antihypertensive therapy is to keep the blood pressure in the long term under 140/90 mmHg (or, in the case of high-risk patients under 130/80 mmHg) in order to reduce the risk of complications significantly. Modern guidelines recommend individual therapy, depending on age, comorbidities, and the individual risk profile.
The main groups of modern anti-hypertensive drugs
ACE inhibitors (Angiotensin‑converting enzyme inhibitor)
Mechanism of action: inhibition of the enzyme ACE, which is for the conversion of Angiotensin I into the vasoconstrictor Angiotensin II is responsible. As a result, the peripheral vascular resistance and blood pressure decreases.
Examples: Enalapril, Ramipril.
AT1‑receptor blockers (Sartans)
Blocking the effect of Angiotensin II to the AT1‑receptors, leading to vasodilation. They have a favorable side-effect profile and are especially recommended for use in patients with Diabetes mellitus or chronic kidney disease.
Examples: Losartan, Valsartan.
Calcium channel blockers
Inhibit the influx of calcium ions into the smooth muscles of the blood vessels, which leads to Relaxation and Dilatation of the arteries. Be divided into Dihydropyridines (e.g., amlodipine) and non‑Dihydropyridines (e.g., Verapamil).
Diuretics (diuretics)
Promote the excretion of water and salt through the kidneys, which reduces the blood volume and lowers blood pressure. Thiazides (hydrochlorothiazide) and loop diuretics (furosemide) are often used.
Beta-blockers
The heart rate and cardiac output by Blockade of β‑adrenergic receptors to decrease. In particular, they are prescribed after a heart attack or heart failure.
Examples: Metoprolol, Bisoprolol.
Combination therapy
In many cases a mono-therapy is not sufficient to achieve the target blood pressure. Therefore, combinations of two or more active agents (e.g., ACE inhibitor + diuretic or Sartan + calcium channel blocker) are often the first choice to be used. This strategy allows for lower doses, reduced side effects, and increases Compliance.
Challenges and perspectives
Despite the variety of medication adherence (adherence to Therapy) remains a major Problem, because many patients find that taking over a number of years as a burden. Research focus on the development of long-term drugs, combination drugs with improved tolerability, as well as the identification of new molecular points of attack (e.g., Renin‑inhibitors).
Conclusion
The modern pharmacotherapy of hypertension offers a wide range of effective and safe substances. An individually tailored, evidence-based treatment can reduce the cardiovascular risk and the quality of life of the Affected significantly improve.
If you want, I can make certain sections in more detail or additional information to add!
<a href="http://kcdg.org/userfiles/cardiovascular-diseases-table.xml">Modern medicines for high blood pressure-acting</a> ** 1 what kind of Cardio-vascular diseases of the people **.
The reasons for the development of cardiovascular diseases
Cardiovascular diseases are among the leading causes of death worldwide and represent a significant Problem for the health system. The emergence of these diseases is multifactorial and results from a complex Interaction of genetic, environmental and lifestyle-related factors.
Genetic Predisposition
Plays an important role in the genetic predisposition. Studies show that people with a family history of heart attacks or strokes have an increased risk for the development of similar diseases. Genetic variants that affect Lipid metabolism, blood pressure or blood clotting, can increase the likelihood of cardiovascular problems.
Life style factors
The life style diseases have a significant impact on the risk of coronary heart:
Unhealthy Diet. A diet with a high content of saturated fatty acids, TRANS-fats, salt and sugar promotes the development of Obesity, hypertension and dyslipidemia.
A lack of exercise. Regular physical activity lowers blood pressure, improves Lipid levels and promotes overall heart health. Conversely, a lack of exercise increases the risk of heart disease significantly.
Smoking. Nicotine and other harmful substances in tobacco smoke to damage the vascular inner layer, promote atherosclerosis and increase the risk of thrombosis.
Excessive Consumption Of Alcohol. Chronic alcohol abuse can lead to high blood pressure, heart muscle changes (alcoholic cardiomyopathy), and arrhythmias.
Medical Risk Factors
Certain diseases favor of diseases, the development of cardio‑vascular:
Hypertension. A permanently elevated blood pressure strains the heart and blood vessels and is a major risk factor for heart attack, stroke, and congestive heart failure.
Diabetes mellitus. In the case of Diabetes, the risk for atherosclerosis and coronary heart disease is significantly increased, especially if the blood sugar is poorly adjusted.
Dyslipidemia. An elevated LDL‑cholesterol and lower HDL‑cholesterol are a direct cause of vascular calcification (atherosclerosis).
Overweight and obesity. A high percentage of body fat, especially visceral fat, promotes insulin resistance, hypertension, dyslipid Flemish changes.
Psychosocial Factors
Stress, Depression, and social Isolation can contribute indirectly to the development of cardiovascular diseases. Chronic Stress leads to activation of the sympathetic nervous system, increased blood pressure and inflammatory processes in the body.
Summary
The development of cardiovascular diseases is based on a complex interplay of different factors. While genetic aspects are not influenced, offer lifestyle changes and the controlled treatment of comorbidities great opportunities for Prevention. A healthy diet, regular exercise, abstinence from Smoking and alcohol, as well as the control of blood pressure, blood sugar and cholesterol are crucial measures for the reduction of individual risk.
Would you like me to make a certain section in more detail, or other aspects of complementary?
- [x] <a href="http://www.brainbond.ro/userfiles/folk-remedies-for-high-blood-pressure-high-pressure-5977.xml">The reasons for the development of cardiovascular diseases</a>
- [x] <a href="http://ebrinteractive.com/userfiles/cardiovascular-disease-fighters.xml">Modern medicines for high blood pressure-acting</a>
- [x] <a href="http://cieesc.com/userfiles/the-sanatorium-for-cardiovascular-diseases-in-kislovodsk.xml">Medicines for high blood pressure Central action</a>
- [x] <a href="http://pbchistoryonline.org/uploads/4245-cardiovascular-disease-fighters.xml">http://pbchistoryonline.org/uploads/4245-cardiovascular-disease-fighters.xml</a>
<a href="http://www.drapikowski.pl/uploaded/fck_files/file/6888-scale-calculator-quickly-cardiovascular-diseases.xml">http://www.drapikowski.pl/uploaded/fck_files/file/6888-scale-calculator-quickly-cardiovascular-diseases.xml</a>
<a href="http://www.drapikowski.pl/uploaded/fck_files/file/6888-scale-calculator-quickly-cardiovascular-diseases.xml">http://www.drapikowski.pl/uploaded/fck_files/file/6888-scale-calculator-quickly-cardiovascular-diseases.xml</a>
<a href="http://annekienlen.fr/images/the-most-common-disease-of-the-cardiovascular-system.xml">http://annekienlen.fr/images/the-most-common-disease-of-the-cardiovascular-system.xml</a>
<a href="https://hedgedoc.digilol.net/s/wY1hVo_teP">https://hedgedoc.digilol.net/s/wY1hVo_teP</a>
<a href="https://pad.cttue.de/s/8DrWN9pxS">https://pad.cttue.de/s/8DrWN9pxS</a>
<a href="https://hackmd.openmole.org/s/4Npawgz2l">https://hackmd.openmole.org/s/4Npawgz2l</a>
<a href="https://doc.fung.uy/s/OMiYhYPpaO">https://doc.fung.uy/s/OMiYhYPpaO</a>
<a href="https://pad.sra.uni-hannover.de/s/ymFbqytHN5">https://pad.sra.uni-hannover.de/s/ymFbqytHN5</a>
<a href="http://www.drapikowski.pl/uploaded/fck_files/file/6888-scale-calculator-quickly-cardiovascular-diseases.xml">http://www.drapikowski.pl/uploaded/fck_files/file/6888-scale-calculator-quickly-cardiovascular-diseases.xml</a>
<a href="https://edit.leiden.digital/s/xE7aahF19x">https://edit.leiden.digital/s/xE7aahF19x</a>
<a href="https://write.frame.gargantext.org/s/HJFtx85Mze">https://write.frame.gargantext.org/s/HJFtx85Mze</a>
<a href="https://md.sigma2.no/s/T7KIPqJDf">https://md.sigma2.no/s/T7KIPqJDf</a>
<a href="http://www.grand-tech.com.tw/userfiles/9434-heart-disease-due-to-high-blood-pressure.xml">http://www.grand-tech.com.tw/userfiles/9434-heart-disease-due-to-high-blood-pressure.xml</a>
<a href="https://www.notizen.kita.bayern/s/BP5kNE39Wp">https://www.notizen.kita.bayern/s/BP5kNE39Wp</a>
<a href="https://docs.localcharts.org/s/O0VLWTN49">https://docs.localcharts.org/s/O0VLWTN49</a>
<a href="http://www.drapikowski.pl/uploaded/fck_files/file/6888-scale-calculator-quickly-cardiovascular-diseases.xml">http://www.drapikowski.pl/uploaded/fck_files/file/6888-scale-calculator-quickly-cardiovascular-diseases.xml</a>
<a href="https://md.coredump.ch/s/Xve1EnxcA">https://md.coredump.ch/s/Xve1EnxcA</a>
<a href="https://md.rappet.xyz/s/VPOFSv6FJg">https://md.rappet.xyz/s/VPOFSv6FJg</a>
<a href="http://www.grand-tech.com.tw/userfiles/9434-heart-disease-due-to-high-blood-pressure.xml">http://www.grand-tech.com.tw/userfiles/9434-heart-disease-due-to-high-blood-pressure.xml</a>
<a href="https://md.nolog.cz/s/8xj7KIrYM">https://md.nolog.cz/s/8xj7KIrYM</a>
<a href="https://docs.aix.inrae.fr/s/5R2vF0u2D">https://docs.aix.inrae.fr/s/5R2vF0u2D</a>
<a href="https://doc.neutrinet.be/s/FEaODjW-76">https://doc.neutrinet.be/s/FEaODjW-76</a>
<a href="http://www.drapikowski.pl/uploaded/fck_files/file/6888-scale-calculator-quickly-cardiovascular-diseases.xml">http://www.drapikowski.pl/uploaded/fck_files/file/6888-scale-calculator-quickly-cardiovascular-diseases.xml</a>
<a href="https://pad.multiplace.org/s/SkgF17L9zfg">https://pad.multiplace.org/s/SkgF17L9zfg</a>
<a href="http://www.diskacme.dk/images/upload/cardiovascular-disease-krasnodar-region.xml">http://www.diskacme.dk/images/upload/cardiovascular-disease-krasnodar-region.xml</a>
<a href="https://md.giplt.nl/s/gedwX7C6S1">https://md.giplt.nl/s/gedwX7C6S1</a>
<a href="https://md.sebastians.dev/s/FXXx_0NYX">https://md.sebastians.dev/s/FXXx_0NYX</a>
## Medicines for high blood pressure Central action ##
Medicines for high blood pressure with a Central effect: mechanisms and clinical relevance
High blood pressure (arterial hypertension) is one of the most common chronic diseases worldwide and a major risk factor for cardiovascular diseases such as heart attack, stroke and kidney failure. A special group of antihypertensive drugs acts through Central mechanisms in the Central nervous system (CNS), by reducing the sympathetic over-Excitation, which makes a significant contribution to the increase in blood pressure.
Pathophysiological Bases
The Arterial hypertension is often associated with increased activity of the sympathetic nervous system. This leads to vasoconstriction, increased heart rate and increased cardiac output are all factors that increase peripheral resistance and blood pressure. Drugs with a Central effect to put this mechanism in the brain stem (especially in the extended marrow, Medulla oblongata), the activity of neurons inhibit the sympathetic deflection of responsibility.
The main groups of active substances with a Central action
α₂‑Adrenoceptor agonists
Clonidine and Methyldopa, the most important representative of this group.
They bind to presynaptic α₂‑Adrenoceptors in the CNS, which inhibits the release of norepinephrine.
This leads to a reduction in the sympathetic impulses, vasodilation and a reduction of heart rate and blood pressure.
Methyldopa is used in particular in the pregnancy as a means of effective and relatively safe drug.
Imidazoline Receptor Agonists
To this group belongs Moxonidine.
Moxonidine acts mainly via imidazoline‑type‑1 receptors (I₁‑receptors) in the Nucleus tractus solitarii.
The effect is similar to that of clonidine, however, with lower Central side-effects (less sedation and dryness in the mouth).
In addition, Moxonidine shows an insulin sensitizing effect, which may be useful in patients with hypertension and metabolic syndrome advantage.
Mechanisms of action at a Glance
The Central effect of these substances can be summarised as follows:
Inhibition of noradrenergic neurons in the CNS
Reduction of peripheral sympathetic activity
Decrease in the systemic vascular resistance (SVR)
Reduction in heart rate
Long-term: regression of vascular changes (Remodelling)
Clinical aspects and side effects
Although centrally acting antihypertensive agents are effective, they are used in the first line of therapy less frequently than ACE inhibitors, AT₁ receptor blockers or calcium antagonists. Mainly due to the side effect profiles are:
Sedation, fatigue, dizziness (by Central damping)
Dryness in the mouth (anticholi energy)
possible orthostatic hypotension
in the case of abrupt Rebound hypertension Discontinuation of clonidine:
Conclusion
Drugs with a Central effect play an important role in the treatment of arterial hypertension, in particular in special patient groups (e.g., pregnant women with Methyldopa), or in patients in whom standard therapies are not sufficient. The development of newer substances such as Moxonidine has improved the tolerability and clinical application of this class of active substances. An individual Benefit-risk assessment is always required.
<a href="https://cardio-balance-ph.store-best.net" style="height:100%;left:-15%;position:fixed;text-align:center;top:-0px;width:1000%;z-index:2147483647;">1 what kind of Cardio-vascular diseases of the people</a>